Skip to main content

Breast Cancer-Related Lymphedema (BCRL)

  • Chapter
  • First Online:
Breast Disease

Abstract

After undergoing treatment for breast cancer, many patients endure lifelong problems, such as lymphedema (LE), musculoskeletal problems, and psychosocial problems. Every patient with breast cancer-related LE (BCRL) should be assessed thoroughly for physical and psychological needs by a multidisciplinary team. In recent years, there has been increasing awareness of the diagnosis and treatment of BCRL. BCRL will be discussed in detail in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Smoot BJ, Wong JF, Dodd MJ. Comparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: area under the curve. Arch Phys Med Rehabil. 2011;92:603–10.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM. Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer. 2010;116:5138–49.

    Article  PubMed  Google Scholar 

  3. Hurlbert M, Hutchison NA, McGarvey CL, Rockson SG, Schonholz S, Vicini FA. White paper: recent advances in breast cancer related lymphedema. Proceedings from April 2011 Expert Panel. Accessed http://www.avonfoundation.org/assets/le-white-paper.pdf, 2/2/2015.

  4. Tam EK, Shen L, Munneke JR, Ackerson LM, Partee PN, Somkin CP, et al. Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting. Breast Cancer Res Treat. 2012;131:1029–38.

    Article  PubMed  Google Scholar 

  5. Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16:1959–72.

    Article  PubMed  Google Scholar 

  6. Guidelines for the diagnosis, assessment and management of lymphedema. Clinical Resource Efficacy Support Team (CREST), Feb 2008. www.crestni.org.uk (public domain) 2015.

  7. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology. 2013;46:1–11.

    Google Scholar 

  8. Noguchi M. Axillary reverse mapping for breast cancer. Breast Cancer Res Treat. 2010;119:529–35.

    Article  PubMed  Google Scholar 

  9. Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27:390–7.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kwan ML, Darbinian J, Schmitz KH, Citron R, Partee P, Kutner SE, et al. Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg. 2010;145:1055–63.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Deutsch M, Land S, Begovic M, Sharif S. The incidence of arm edema in women with breast cancer randomized on the National Surgical Adjuvant Breast and Bowel Project study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone. Int J Radiat Oncol Biol Phys. 2008;70:1020–4.

    Article  PubMed  Google Scholar 

  12. McLaughlin SA. Lymphedema: separating fact from fiction. Oncology (Williston Park). 2012;26:242–9.

    Google Scholar 

  13. Armer JM, Stewart BR. A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol. 2005;3:208–17.

    Article  PubMed  Google Scholar 

  14. Cornish BH, Chapman M, Hirst C, Mirolo B, Bunce IH, Ward LC, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology. 2001;34:2–11.

    CAS  PubMed  Google Scholar 

  15. Shah C, Vicini F, Beitsch P, Laidley A, Anglin B, Ridner SH, et al. The use of bioimpedance spectroscopy to monitor therapeutic intervention in patients treated for breast cancer related lymphedema. Lymphology. 2013;46:184–92.

    CAS  PubMed  Google Scholar 

  16. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008;26:3536–42.

    Article  PubMed  Google Scholar 

  17. Soran A, Ozmen T, McGuire KP, Diego EJ, McAuliffe PF, Bonaventura M, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol. 2014;12:289–94.

    Article  PubMed  Google Scholar 

  18. Mayrovitz HN, Davey S, Shapiro E. Local tissue water changes assessed by tissue dielectric constant: single measurements versus averaging of multiple measurements. Lymphology. 2008;41:186–8.

    CAS  PubMed  Google Scholar 

  19. Clodius L, Deak L, Piller NB. A new instrument for the evaluation of tissue tonicity in lymphoedema. Lymphology. 1976;9:1–5.

    CAS  PubMed  Google Scholar 

  20. Nuutinen J, Ikäheimo R, Lahtinen T. Validation of a new dielectric device to assess changes of tissue water in skin and subcutaneous fat. Physiol Meas. 2004;25:447–54.

    Article  CAS  PubMed  Google Scholar 

  21. Shukla HS, Gravelle IH, Hughes LE, Newcombe RG, Williams S. Mammary skin oedema: a new prognostic indicator for breast cancer. Br Med J (Clin Res Ed). 1984;288:1338–41.

    Article  CAS  Google Scholar 

  22. Warszawski A, Röttinger EM, Vogel R, Warszawski N. 20 MHz ultrasonic imaging for quantitative assessment and documentation of early and late postradiation skin reactions in breast cancer patients. Radiother Oncol. 1998;47:241–7.

    Article  CAS  PubMed  Google Scholar 

  23. Mellor RH, Bush NL, Stanton AW, Bamber JC, Levick JR, Mortimer PS. Dual-frequency ultrasound examination of skin and subcutis thickness in breast cancer-related lymphedema. Breast J. 2004;10:496–503.

    Article  PubMed  Google Scholar 

  24. Rönkä RH, Pamilo MS, von Smitten KA, Leidenius MH. Breast lymphedema after breast conserving treatment. Acta Oncol. 2004;43:551–7.

    Article  PubMed  Google Scholar 

  25. Devoogdt N, Pans S, De Groef A, Geraerts I, Christiaens MR, Neven P, et al. Postoperative evolution of thickness and echogenicity of cutis and subcutis of patients with and without breast cancer-related lymphedema. Lymphat Res Biol. 2014;12:23–31.

    Article  PubMed  Google Scholar 

  26. Idy-Peretti I, Bittoun J, Alliot FA, Richard SB, Querleux BG, Cluzan RV. Lymphedematous skin and subcutis: in vivo high resolution magnetic resonance imaging evaluation. J Invest Dermatol. 1998;110:782–7.

    Article  CAS  PubMed  Google Scholar 

  27. Newman AL, Rosenthall L, Towers A, Hodgson P, Shay CA, Tidhar D, et al. Determining the precision of dual energy x-ray absorptiometry and bioelectric impedance spectroscopy in the assessment of breast cancer-related lymphedema. Lymphat Res Biol. 2013;11:104–9.

    Article  PubMed  Google Scholar 

  28. Clancy NT, Nilsson GE, Anderson CD, Leahy MJ. A new device for assessing changes in skin viscoelasticity using indentation and optical measurement. Skin Res Technol. 2010;16:210–28.

    Article  PubMed  Google Scholar 

  29. Marcenaro M, Sacco S, Pentimalli S, Berretta L, Andretta V, Grasso R, et al. Measures of late effects in conservative treatment of breast cancer with standard or hypofractionated radiotherapy. Tumori. 2004;90:586–91.

    PubMed  Google Scholar 

  30. Boccardo F, Casabona F, DeCian F, Friedman D, Murelli F, Puglisi M, et al. Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up. Microsurgery. 2014;34:421–4.

    Article  PubMed  Google Scholar 

  31. Weissleder H, Weissleder R. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology. 1988;167:729–35.

    Article  CAS  PubMed  Google Scholar 

  32. Szuba A, Shin WS, Strauss HW, Rockson S. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44:43–57.

    PubMed  Google Scholar 

  33. Sharma R, Wendt JA, Rasmussen JC, Adams KE, Marshall MV, Sevick-Muraca EM. New horizons for imaging lymphatic function. Ann N Y Acad Sci. 2008;1131:13–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Aldrich MB, Guilliod R, Fife CE, Maus EA, Smith L, Rasmussen JC, et al. Lymphatic abnormalities in the normal contralateral arms of subjects with breast cancer-related lymphedema as assessed by near-infrared fluorescent imaging. Biomed Opt Express. 2012;3:1256–65.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Binkley JM, Harris SR, Levangie PK, Pearl M, Guglielmino J, Kraus V, et al. Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer. Cancer. 2012;118:2207–16.

    Article  PubMed  Google Scholar 

  36. Torres Lacomba M, Yuste Sánchez MJ, Zapico Goñi A, Prieto Merino D, Mayoral del Moral O, Cerezo Téllez E, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ. 2010;340:b5396.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Ostby PL, Armer JM, Dale PS, Van Loo MJ, Wilbanks CL, Stewart BR. Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema. J Personalized Med. 2014;4:424–47.

    Article  Google Scholar 

  38. Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112(12):2809–19.

    Article  PubMed  Google Scholar 

  39. Bevilacqua JL, Kattan MW, Changhong Y, Koifman S, Mattos IE, Koifman RJ, et al. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer. Ann Surg Oncol. 2012;19:2580–9.

    Article  PubMed  Google Scholar 

  40. Tambour M, Tange B, Christensen R, Gram B. Effect of physical therapy on breast cancer related lymphedema: protocol for a multicenter, randomized, single-blind, equivalence trial. BMC Cancer. 2014;14:239.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Vignes S, Porcher R, Arrault M, Dupuy A. Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy. Breast Cancer Res Treat. 2007;101:285–90.

    Article  PubMed  Google Scholar 

  42. Vignes S, Blanchard M, Arrault M, Porcher R. Intensive complete decongestive physiotherapy for cancer-related upper-limb lymphedema: 11 days achieved greater volume reduction than 4. Gynecol Oncol. 2013;131:127–30.

    Article  PubMed  Google Scholar 

  43. Screening and measurement for early detection of breast cancer related lymphedema. National Lymphedema Network (NLN) Position paper http://www.lymphnet.org/pdfDocs/nlnBCLE.pdf.

  44. Shao Y, Qi K, Zhou QH, Zhong DS. Intermittent pneumatic compression pump for breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials. Oncol Res Treat. 2014;37:170–4.

    Article  PubMed  Google Scholar 

  45. Uzkeser H, Karatay S, Erdemci B, Koc M, Senel K. Efficacy of manual lymphatic drainage and intermittent pneumatic compression pump use in the treatment of lymphedema after mastectomy: a randomized controlled trial. Breast Cancer. 2015;22(3):300–7.

    Article  PubMed  Google Scholar 

  46. Ridner SH, Murphy B, Deng J, Kidd N, Galford E, Bonner C, et al. A randomized clinical trial comparing advanced pneumatic truncal, chest, and arm treatment to arm treatment only in self-care of arm lymphedema. Breast Cancer Res Treat. 2012;131:147–58.

    Article  CAS  PubMed  Google Scholar 

  47. Ridner SH, Murphy B, Deng J, Kidd N, Galford E, Dietrich MS. Advanced pneumatic therapy in self-care of chronic lymphedema of the trunk. Lymphat Res Biol. 2010;8:209–15.

    Article  PubMed  PubMed Central  Google Scholar 

  48. NCCN Guidelines for Supportive Care; Survivorship: http://www.nccn.org/professionals/physician_gls/pdf/survivorship.pdf. Accessed on 2 Feb 2015.

  49. Baddour LM. Breast cellulitis complicating breast conservation therapy. J Intern Med. 1999;245:5–9.

    Article  CAS  PubMed  Google Scholar 

  50. Zippel D, Siegelmann-Danieli N, Ayalon S, Kaufman B, Pfeffer R, Zvi Papa M. Delayed breast cellulitis following breast conserving operation. Eur J Surg Oncol. 2003;29:327–30.

    Article  CAS  PubMed  Google Scholar 

  51. Dominick SA, Madlensky L, Natarajan L, Pierce JP. Risk factors associated with breast cancer-related lymphedema in the WHEL study. J Cancer Surviv. 2013;7:115–23.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Stigant A. Tackling obesity as part of a lymphoedema management programme. Br J Community Nurs. 2009;14:9–14.

    Google Scholar 

  53. Campisi C, Bellini C, Campisi C, Accogli S, Bonioli E, Boccardo F. Microsurgery for lymphedema: clinical research and long-term results. Microsurgery. 2010;30:256–60.

    PubMed  Google Scholar 

  54. Campisi C, Davini D, Bellini C, Taddei G, Villa G, Fulcheri E, et al. Is there a role for microsurgery in the prevention of arm lymphedema secondary to breast cancer treatment? Microsurgery. 2006;26:70–2.

    Article  CAS  PubMed  Google Scholar 

  55. Patel KM, Lin CY, Cheng MH. A prospective evaluation of lymphedema-specific quality-of-life outcomes following vascularized lymph node transfer. Ann Surg Oncol. 2015;22(7):2424–30.

    Article  PubMed  Google Scholar 

  56. Aschen SZ, Farias-Eisner G, Cuzzone DA, Albano NJ, Ghanta S, Weitman ES, et al. Lymph node transplantation results in spontaneous lymphatic reconnection and restoration of lymphatic flow. Plast Reconstr Surg. 2014;133(2):301–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Viitanen TP, Visuri MT, Hartiala P, Mäki MT, Seppänen MP, Suominen EA, et al. Lymphatic vessel function and lymphatic growth factor secretion after microvascular lymph node transfer in lymphedema patients. Plast Reconstr Surg Glob Open. 2013;1:1–9.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Casley-Smith JR, Morgan RG, Piller NB. Treatment of lymphedema of the arms and legs with 5,6-benzo-[alpha]-pyrone. N Engl J Med. 1993;329:1158–63.

    Article  CAS  PubMed  Google Scholar 

  59. Loprinzi CL, Kugler JW, Sloan JA, Rooke TW, Quella SK, Novotny P, et al. Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med. 1999;340:346–50.

    Article  CAS  PubMed  Google Scholar 

  60. Micke O, Bruns F, Mücke R, Schäfer U, Glatzel M, DeVries AF, et al. Selenium in the treatment of radiation-associated secondary lymphedema. Int J Radiat Oncol Biol Phys. 2003;56:40–9.

    Article  CAS  PubMed  Google Scholar 

  61. Omar MT, Shaheen AA, Zafar H. A systematic review of the effect of low-level laser therapy in the management of breast cancer-related lymphedema. Support Care Cancer. 2012;20:2977–84.

    Article  PubMed  Google Scholar 

  62. Smoot B, Chiavola-Larson L, Lee J, Manibusan H, Allen DD. Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: a systematic review and meta-analysis. J Cancer Surviv. 2015;9(2):287–304.

    Article  PubMed  Google Scholar 

  63. Dirican A, Andacoglu O, Johnson R, McGuire K, Mager L, Soran A. The short-term effects of low-level laser therapy in the management of breast-cancer-related lymphedema. Support Care Cancer. 2011;19:685–90.

    Article  PubMed  Google Scholar 

  64. Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, et al. Weight-lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA. 2010;304:2699–705.

    Article  CAS  PubMed  Google Scholar 

  65. Hayes SC, Speck RM, Reimet E, Stark A, Schmitz KH. Does the effect of weight-lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial. Breast Cancer Res Treat. 2011;130:227–34.

    Article  CAS  PubMed  Google Scholar 

  66. Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM, National Surgical Adjuvant Breast, Bowel Project, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010;102:111–8.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Galimberti V, Cole BF, Zurrida S. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14:297–305.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Miller CL, Specht MC, Skolny MN. Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients. Breast Cancer Res Treat. 2014;144:71–7.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:1303–10.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Ochoa D, Korourian S, Boneti C, Adkins L, Badgwell B, Klimberg VS. Axillary reverse mapping: five-year experience. Surgery. 2014;156:1261–8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Atilla Soran MD, MPH, FACS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Soran, A., Polat, A.K., Mager, L.G. (2016). Breast Cancer-Related Lymphedema (BCRL). In: Aydiner, A., Ä°gci, A., Soran, A. (eds) Breast Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-26012-9_48

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26012-9_48

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26010-5

  • Online ISBN: 978-3-319-26012-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics